Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 24 % of short-term debt in 2024; threshold 65 %.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
EU BIOTECH CAMPUS from Charleroi, company number BE0776668706, closed financial year 2024 with a result of € -175,235 after tax. For that financial year EU BIOTECH CAMPUS recorded a gross margin of € 89,721 and equity of € 4 million. Compared with financial year 2023, the result moved from € -292,416 to € -175,235. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 18, 2025.
€ 4 million
▼ 9% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -175,235
▲ 40 % less loss than in 2023
Profit after tax over the fiscal year.
€ 210,543
▼ 92% vs 2023
Cash and bank balances on the last day of the fiscal year.
People and assets in 2024
€ 274,703
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,519
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 200,000
Loans from banks and other lenders, long and short.
€ 3.6 million
▲ € 3.5 million vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 31,308
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Gross margin | € 35,336 | € -318,967 | € 89,721 | ▲ € 408,689 |
| Profit after taxes | € 34,546 | € -292,416 | € -175,235 | ▲ € 117,181 |
| Equity | € 4,694,546 | € 4,402,130 | € 4,026,129 | ▼ 9% |
| Total debts | € 612,359 | € 170,013 | € 4,534,469 | ▲ € 4.4 million |
| Cash | € 4,485,070 | € 2,510,526 | € 210,543 | ▼ 92% |
| Land & buildings | € 47,328 | € 47,328 | € 47,328 | |
| Retained profit | € 34,546 | € -257,870 | € -433,105 | ▼ € 175,235 |
| Bank debt | € 0 | € 0 | € 200,000 | |
| Balance sheet total | € 5,306,904 | € 4,572,143 | € 8,560,598 | ▲ 87% |
Key figures of EU BIOTECH CAMPUS, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to EU BIOTECH CAMPUS?
What happened at EU BIOTECH CAMPUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- BIOPARK DEV SA stepped down as director. NBB
- ESSENSCIA ASBL stepped down as director. NBB
- UNIVERCELLS SA stepped down as director. NBB
- LE FOREM EtUtPub stepped down as director. NBB
- BIOWIN ASBL stepped down as director. NBB
- CEFOCHIM/APTASKIL ASBL stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 175,235. filed late Source: NBB ↗
- BIOPARK DEV SA became a director. NBB
In short
From € 34,546 profit in 2022 to € 175,235 loss in 2024.
Best year ever: 2022, with € 34,546 profit.
Management
Directors
According to the 2024 annual accounts
Director · represented by Dominique Demonté
since 2024 · until 2028
Chairman of the board · represented by Frédéric DRUCK
Also active at: AKT For Wallonia, FOST PLUS, aptaskil, INNOVATION FUND, BlueChem, Catalisti
since 2021 · until 2025
since 2021 · until 2025
Vice-chairman of the board · represented by Eric VAN SEVENANT
Also active at: MISSION REGIONALE POUR L'INSERTION ET L'EMPLOI A CHARLEROI, MISSION REGIONALE POUR L'EMPLOI ET L'INSERTION DU SUD DE L'ENTRE-SAMBRE-ET-MEUSE, Mission régionale pour l'Insertion et l'Emploi pour Verviers, Mission régionale pour l'Emploi de liège, Mission régionale pour l'emploi du Centre, TECHNIFUTUR, Observatoire de l'Intégration, TECHNOFUTUR TIC +10 more
since 2021 · until 2025
Director · represented by Mélanie MESTDAGT
since 2021 · until 2025
Director · represented by Thierry JOSEPHY
since 2021 · until 2025
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Rue Clément Ader 10 box /
6041 Charleroi
Active since 8 January 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →Brussels South Charleroi BioPark Dev same network
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0776.668.706
- VAT number
- BE 0776.668.706
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- EU BIOTECH CAMPUS · EBC
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 29 October 2021
- Peppol
- Active · Active since 5 Dec 2025
- Contact
- [email protected]
- Activities · NACE
Overige verenigingen, neg
Overige zakelijke dienstverlening, neg